Interestingly, the dual BBB and tumor targeting strategy resulted in a marked therapeutic efficacy of NPs-ZOL-Tf since, in mice treated with this formulation, a stabilization of the disease and a complete response with regression of tumor and cure in some cases were observed. The gene discussed is TF; the disease is neoplasm.